Advanced Search
Conferences

16th Human Proteome Organization World Congress

The European Proteomics Association (EuPA) and the British Society for Proteome Research (BSPR) is absolutely delighted to welcome you to the 16th Annual World Congress of the Human Proteome Organisation which will be held in Dublin on 17-21st September 2017.

The Congress is also the 11th Annual EuPA meeting and 14th Annual BSPR Meeting. The congress is to be held in a state-of-the-art convention centre in the heart of Dublin a world renowned and historic city that’s vibrant, friendly and energetic.

Past
  • September 17-21, 2017

  • HUPO2017

  • The Convention Centre Dublin (The CCD), Dublin, Ireland

Schedule

18 September

14:00 to 14:15

S Dijon

Quantitative Proteomics to Investigate the Effects of a Prototype Modified Risk Tobacco Product (pMRTP) and Smoking Cessation on Mouse Lung Proteome

HUPO 2017 Dijon Quantitative proteomics to investigate the effects of a prototype modified risk tobacco product (pMRTP)
1690 KB

18 September

14:30 to 14:45

C Nury

Proteomics as Part of a Multi-Omics Systems Toxicological Assessment of a Mentholated Candidate Modified Risk Tobacco Product

HUPO 2017 Nury Proteomics as part of a multi omics systems toxicological assessment
1414 KB

18 September

16:30 to 16:45

T Schneider

Integration of Targeted Proteomics into Systems Toxicology Approach: Candidate Modified-Risk Tobacco Product Assessment using Nasal Cultures

HUPO 2017 Schneider Integration of targeted proteomics into systems toxicology approach
1487 KB
PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts to develop and assess products that have the potential to reduce individual risk and population harm associated with tobacco use. This site is for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not for advertising or marketing. It is not intended for use by consumers.

Our RRPs

Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. Our RRPs are smoke-free products that produce an aerosol that contains far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.